Back to top

Profound Medical announces first commercial BPH treatment using TULSA-AI

Profound Medical (PROF) announces that the first commercial benign prostatic hyperplasia, BPH, treatment utilizing the TULSA-PRO system’s new TULSA...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Invesco Dorsey Wright Industrials Momentum ETF (PRN)

Profound Medical (PROF)